🏢 What kind of company is Integer Holdings?

Integer Holdings (ITGR) is a US medical device company that provides medical device components and contract manufacturing. It designs and manufactures medical device components for cardiovascular and neuromodulation applications as well as medical batteries, supplying them to medical device OEMs, and is exposed to medical device outsourcing demand.

Its core business is contract manufacturing, which designs and produces medical device components for cardiovascular and neuromodulation use, along with medical batteries, for delivery to medical device companies. With strengths in medical device component technology, a large customer base, and benefits from the expansion of outsourcing, it is a medical device company whose earnings are tied to outsourcing demand and order intake.

💰 How does Integer Holdings make money?

Recent revenue is centered on medical device components and contract manufacturing, including cardiovascular and neuromodulation products, with outsourcing demand, order intake, new products, and margins driving results. Medical device component technology and a large customer base provide stable demand, while the expansion of medical device outsourcing adds growth. In an environment where results are sensitive to customer demand and supply chains, outsourcing demand, order intake, and margins dictate the earnings trajectory.

Market capitalization stands at $4.1B, with 11,000명 employees.

As a medical device contract manufacturer, it occupies a position frequently compared with peers such as TFX (Teleflex), MMSI (Merit Medical), and GMED (Globus Medical). Its strengths include medical device component technology, a large customer base, and benefits from expanding outsourcing, with results linked to medical device outsourcing demand and order intake.

📈 Integer Holdings outlook and stock price trends

The expansion of medical device outsourcing, demand for cardiovascular and neuromodulation components, new products and acquisitions, and a higher mix of high-value products are the key medium- to long-term drivers. Medical device component technology and a large customer base provide stable demand, while the expansion of outsourcing supports growth. On the other hand, in the near term, potential volatility factors include order changes driven by customer demand fluctuations, supply chain and cost variances, acquisition integration burdens, and intensifying contract manufacturing competition.

• Expansion of medical device outsourcing
• Demand for cardiovascular and neuromodulation components
• New products and acquisitions

⚔️ Integer Holdings core strengths and risks

Medical device component technology, a large customer base, and benefits from outsourcing expansion are strengths, while customer demand fluctuations, supply chain and cost variances, acquisition integration burdens, and intensifying competition are the core risks.

🔄 Integer Holdings competitors and related (thematic) stocks

Direct comparable names in the medical device space include TFX (Teleflex), MMSI (Merit Medical Systems), and GMED (Globus Medical). Related names grouped under the medical device theme include ICUI (ICU Medical) and BAX (Baxter International), which share medical device demand.

✅ Investor checklist for Integer Holdings

Key items to review when considering Integer Holdings. Medical device outsourcing demand, customer orders, new products, supply chain and costs, and margins act as the key short- and medium-term variables.

Customer demand fluctuations affecting orders and results are a core risk. Supply chain and cost variances, acquisition-related integration cost burdens, and intensifying competition in medical device contract manufacturing can also act as swing factors for margins and results.

Integer Holdings is a US medical device contract manufacturer equipped with medical device component technology and a large customer base, with strengths in benefits from outsourcing expansion and high-value products. However, given its sensitivity to customer demand, supply chains, and integration burdens, a dollar-cost averaging approach with a long-term perspective is recommended.